PeterLabs Holdings Berhad (0171.KL)
- Previous Close
0.3350 - Open
0.3300 - Bid 0.3500 x --
- Ask 0.3550 x --
- Day's Range
0.3250 - 0.3550 - 52 Week Range
0.1700 - 0.3550 - Volume
1,073,600 - Avg. Volume
2,296,791 - Market Cap (intraday)
97.701M - Beta (5Y Monthly) 0.66
- PE Ratio (TTM)
35.50 - EPS (TTM)
0.0100 - Earnings Date --
- Forward Dividend & Yield 0.00 (2.22%)
- Ex-Dividend Date Mar 21, 2024
- 1y Target Est
--
PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products for the livestock industry in Malaysia and internationally. The company operates in Manufacturing and Trading segments. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements. The company markets its animal feed additives under the OsmoFAT brand. It engages in the distribution of consumer goods, including home care, oral care, baby care, and feminine care products, as well as infant and growing up milk powder and grain products to retailers, such as supermarkets, mini markets, sundry shops, convenience stores, pharmacies, petrol kiosks, Chinese medical halls, and hardware stores. The company was founded in 2002 and is headquartered in Nilai, Malaysia.
www.peterlabs.com.my--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 0171.KL
View MorePerformance Overview: 0171.KL
Trailing total returns as of 5/26/2025, which may include dividends or other distributions. Benchmark is FTSE Bursa Malaysia KLCI (^KLSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0171.KL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0171.KL
View MoreValuation Measures
Market Cap
92.20M
Enterprise Value
97.21M
Trailing P/E
32.52
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.52
Price/Book (mrq)
1.16
Enterprise Value/Revenue
0.55
Enterprise Value/EBITDA
20.56
Financial Highlights
Profitability and Income Statement
Profit Margin
1.61%
Return on Assets (ttm)
2.47%
Return on Equity (ttm)
3.86%
Revenue (ttm)
176.03M
Net Income Avi to Common (ttm)
2.84M
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
13.65M
Total Debt/Equity (mrq)
22.65%
Levered Free Cash Flow (ttm)
-67.64k